Repligen Long Term Deferred Charges (Quarterly) Trends

Repligen Corp. (RGEN)

172.26 +2.82 (+1.66%) USD | NASDAQ | Jan 06, 16:00

172.12 -0.14 (-0.08%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for RGEN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Enovis Corp.	--
Teleflex, Inc.	--
Globus Medical, Inc.	--
Perspective Therapeutics, Inc.	--
InfuSystem Holdings, Inc.	--